These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 37022660)

  • 21. Dengue and Zika virus infections are enhanced by live attenuated dengue vaccine but not by recombinant DSV4 vaccine candidate in mouse models.
    Shukla R; Beesetti H; Brown JA; Ahuja R; Ramasamy V; Shanmugam RK; Poddar A; Batra G; Krammer F; Lim JK; Kale S; Lal AA; Swaminathan S; Khanna N
    EBioMedicine; 2020 Oct; 60():102991. PubMed ID: 32949997
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Humoral cross-reactivity between Zika and dengue viruses: implications for protection and pathology.
    Priyamvada L; Hudson W; Ahmed R; Wrammert J
    Emerg Microbes Infect; 2017 May; 6(5):e33. PubMed ID: 28487557
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cross-reactive antibodies facilitate innate sensing of dengue and Zika viruses.
    Aisenberg LK; Rousseau KE; Cascino K; Massaccesi G; Aisenberg WH; Luo W; Muthumani K; Weiner DB; Whitehead SS; Chattergoon MA; Durbin AP; Cox AL
    JCI Insight; 2022 Jun; 7(12):. PubMed ID: 35588060
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Re-evaluation of routine dengue virus serology in travelers in the era of Zika virus emergence.
    van Meer MPA; Mögling R; Klaasse J; Chandler FD; Pas SD; van der Eijk AA; Koopmans MPG; Reusken CBEM; GeurtsvanKessel CH
    J Clin Virol; 2017 Jul; 92():25-31. PubMed ID: 28505571
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A protective Zika virus E-dimer-based subunit vaccine engineered to abrogate antibody-dependent enhancement of dengue infection.
    Slon-Campos JL; Dejnirattisai W; Jagger BW; López-Camacho C; Wongwiwat W; Durnell LA; Winkler ES; Chen RE; Reyes-Sandoval A; Rey FA; Diamond MS; Mongkolsapaya J; Screaton GR
    Nat Immunol; 2019 Oct; 20(10):1291-1298. PubMed ID: 31477918
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Co-infection of dengue and Zika viruses mutually enhances viral replication in the mosquito Aedes aegypti.
    Lin DC; Weng SC; Tsao PN; Chu JJH; Shiao SH
    Parasit Vectors; 2023 May; 16(1):160. PubMed ID: 37165438
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Primary Human Placental Trophoblasts are Permissive for Zika Virus (ZIKV) Replication.
    Aagaard KM; Lahon A; Suter MA; Arya RP; Seferovic MD; Vogt MB; Hu M; Stossi F; Mancini MA; Harris RA; Kahr M; Eppes C; Rac M; Belfort MA; Park CS; Lacorazza D; Rico-Hesse R
    Sci Rep; 2017 Jan; 7():41389. PubMed ID: 28128342
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Armigeres subalbatus is a potential vector for Zika virus but not dengue virus.
    Yang W; Zhao S; Xie Y; Liu T; Kong L; Guo Y; Xie Z; Liu P; Chen XG
    Infect Dis Poverty; 2022 Jun; 11(1):62. PubMed ID: 35658950
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Zika Virus Induced More Severe Inflammatory Response Than Dengue Virus in Chicken Embryonic Livers.
    Zhang Z; Sun M; Deng J; Yu J; Yang X; Zhao W; Chen G; Wang P
    Front Microbiol; 2019; 10():1127. PubMed ID: 31191474
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An hPSC-Derived Tissue-Resident Macrophage Model Reveals Differential Responses of Macrophages to ZIKV and DENV Infection.
    Lang J; Cheng Y; Rolfe A; Hammack C; Vera D; Kyle K; Wang J; Meissner TB; Ren Y; Cowan C; Tang H
    Stem Cell Reports; 2018 Aug; 11(2):348-362. PubMed ID: 29983385
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prior Dengue Virus Exposure Shapes T Cell Immunity to Zika Virus in Humans.
    Grifoni A; Pham J; Sidney J; O'Rourke PH; Paul S; Peters B; Martini SR; de Silva AD; Ricciardi MJ; Magnani DM; Silveira CGT; Maestri A; Costa PR; de-Oliveira-Pinto LM; de Azeredo EL; Damasco PV; Phillips E; Mallal S; de Silva AM; Collins M; Durbin A; Diehl SA; Cerpas C; Balmaseda A; Kuan G; Coloma J; Harris E; Crowe JE; Stone M; Norris PJ; Busch M; Vivanco-Cid H; Cox J; Graham BS; Ledgerwood JE; Turtle L; Solomon T; Kallas EG; Watkins DI; Weiskopf D; Sette A
    J Virol; 2017 Dec; 91(24):. PubMed ID: 28978707
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of Anti-Premembrane Antibody as a Serocomplex-Specific Marker To Discriminate Zika, Dengue, and West Nile Virus Infections.
    Hsieh SC; Tsai WY; Tsai JJ; Stone M; Simmons G; Busch MP; Lanteri M; Stramer SL; Balmaseda A; Harris E; Wang WK
    J Virol; 2021 Sep; 95(19):e0061921. PubMed ID: 34232731
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human T cell responses to Dengue and Zika virus infection compared to Dengue/Zika coinfection.
    Badolato-Corrêa J; Sánchez-Arcila JC; Alves de Souza TM; Santos Barbosa L; Conrado Guerra Nunes P; da Rocha Queiroz Lima M; Gandini M; Bispo de Filippis AM; Venâncio da Cunha R; Leal de Azeredo E; de-Oliveira-Pinto LM
    Immun Inflamm Dis; 2018 Jun; 6(2):194-206. PubMed ID: 29282904
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Experimental Zika virus infection in
    Mourya DT; Gokhale MD; Majumdar TD; Yadav PD; Kumar V; Mavale MS
    Indian J Med Res; 2018 Jan; 147(1):88-96. PubMed ID: 29749366
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CyTOF Profiling of Zika and Dengue Virus-Infected Human Peripheral Blood Mononuclear Cells Identifies Phenotypic Signatures of Monotype Subsets and Upregulation of the Interferon-Inducible Protein CD169.
    Fenutria R; Maringer K; Potla U; Bernal-Rubio D; Evans MJ; Harris E; Rahman AH; Fernandez-Sesma A; Ramos I
    mSphere; 2021 Jun; 6(3):e0050521. PubMed ID: 34160241
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glycosaminoglycan Compositional Analysis of Relevant Tissues in Zika Virus Pathogenesis and in Vitro Evaluation of Heparin as an Antiviral against Zika Virus Infection.
    Kim SY; Koetzner CA; Payne AF; Nierode GJ; Yu Y; Wang R; Barr E; Dordick JS; Kramer LD; Zhang F; Linhardt RJ
    Biochemistry; 2019 Feb; 58(8):1155-1166. PubMed ID: 30698412
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CD4
    Wen J; Wang YT; Valentine KM; Dos Santos Alves RP; Xu Z; Regla-Nava JA; Ngono AE; Young MP; Ferreira LCS; Shresta S
    Cell Rep; 2020 Apr; 31(4):107566. PubMed ID: 32348763
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Understanding Zika Virus Stability and Developing a Chimeric Vaccine through Functional Analysis.
    Xie X; Yang Y; Muruato AE; Zou J; Shan C; Nunes BT; Medeiros DB; Vasconcelos PF; Weaver SC; Rossi SL; Shi PY
    mBio; 2017 Feb; 8(1):. PubMed ID: 28174309
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NS5 Sumoylation Directs Nuclear Responses That Permit Zika Virus To Persistently Infect Human Brain Microvascular Endothelial Cells.
    Conde JN; Schutt WR; Mladinich M; Sohn SY; Hearing P; Mackow ER
    J Virol; 2020 Sep; 94(19):. PubMed ID: 32699085
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improved Immune Responses Against Zika Virus After Sequential Dengue and Zika Virus Infection in Humans.
    Delgado FG; Torres KI; Castellanos JE; Romero-Sánchez C; Simon-Lorière E; Sakuntabhai A; Roth C
    Viruses; 2018 Sep; 10(9):. PubMed ID: 30205518
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.